Osteoporosis in multiple endocrine neoplasia type 1. Severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy

Archives of Surgery

Volumn 134, Issue 10, 1999, Pages 1119-1123

  Burgess, John R ^a   David, Ruben ^a   Greenaway, Timothy M ^a   Parameswaran, V ^a   Shepherd, Joseph J ^b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEMUR FRACTURE; FEMUR NECK; GENE EXPRESSION; HUMAN; HYPERCALCEMIA; LUMBAR SPINE; MULTIPLE ENDOCRINE NEOPLASIA; OSTEOPENIA; OSTEOPOROSIS; PARATHYROIDECTOMY; PATIENT REFERRAL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; OSTEOPOROSIS; PARATHYROIDECTOMY; SEVERITY OF ILLNESS INDEX;

EID: 0032860796     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.10.1119     Document Type: Article

References (24)

1. Ross PD. Risk factors for osteoporotic fracture. Endocrinol Metab Clin North Am. 1993;2:289-301.
2. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteopaenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81: 4007-4012.
3. Sorva A, Valvanne J, Tilvis RS. Serum ionised calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med. 1992;231:309-312.
4. Burgess J, David R, Parameswaran V, et al. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998;133:126-129.
5. Brandi ML, Marx SJ, Aurbach GD, et al. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev. 1987;8:391-405.
6. Padberg B, Schroder S, Capella C, et al. Multiple endocrine neoplasia type 1 (MEN 1) revisited. Virchows Arch. 1995;426:541-548.
7. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN 1 gene in a large kindred with multiple endocrine neoplasia type 1. J Int Med. 1998;243:465-470.
8. Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Int Med. 1995;238:269-280.
9. Skogseid B, Rastad J, Oberg K. Multiple endocrine neoplasia type 1: clinical features and screening. Endocrinol Metab Clin North Am. 1994;23:1-18.
10. Shepherd JJ. The natural history of multiple endocrine neoplasia type 1: highly uncommon or highly unrecognized? Arch Surg. 1991;126:935-952.
11. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989;4:283-291.
12. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxy vitamin D. J Bone Miner Res. 1986;1:377-381.
13. Ljunghall S, Hellman P, Rastad J, et al. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg. 1991;15:681-687.
14. Lundgren E, Rastad J, Thrufjell E, et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;121:287-294.
15. National Institutes of Health Consensus Development Conference on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism. Diagnosis and management of asymptomatic primary hyperparathyroidism. Consens Statement. 1990;8:1-18.
16. Mallette L. Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies. Endocrinol Metab Clin North Am. 1994;1:19-36.
17. Silverberg SJ, Gartenberg F, McMahon DJ, et al. Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 1995;80:729-734.
18. Abugassa S, Nordenstrom J, Eriksson S, et al. Skeletal remineralisation after surgery for primary and secondary hyperparathyroidism. Surgery. 1990;107:128-133.
19. Minisola S, Rosso R, Romagnoli E, et al. Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner. 1993;20:113-123.
20. Burgess JR, Greenaway TM, Parameswaran V, et al. Enteropancreatic malignancy in MEN 1: risk factors and pathogenesis. Cancer 1998;83:428-434.
21. Reid IR. The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinol Metab Clin North Am. 1998;2:389-398.
22. Lindsay R. The role of oestrogen in the prevention of osteoporosis. Endocrinol Metab Clin North Am. 1998;2:399-409.
23. Watts NB. Treatment of osteoporosis with bisphosphonates. Endocrinol Metab Clin North Am. 1998;2:419-439.
24. Collins MT, Skarulis MC, Bilezikian JP, et al. Treatment of hypercalcaemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab. 1998;83:1083-1088.